Skip to main content

Biosyent Inc(RX-X)
TSX Venture

Today's Change
Delayed Last Update

Closing Bell: Biosyent Inc up on Thursday (RX)

Automated Summaries - The Globe and Mail - Thu Apr 4, 4:02PM CDT

Today, Biosyent Inc shares opened at $8.60 and closed at $8.65. It traded at a low of $8.60 to a high of $8.65.

Shares advanced 0.58% from the previous day's close of $8.60.

Today across North America, the TSX Composite closed 0.17% at 22112.46, the S&P 500 closed 0.11% at 5211.49, the Dow Jones Industrial Average closed -0.11% at 39127.14 and the Nasdaq Composite closed 0.23% at 16277.46.

Biosyent Inc traded under RX on the Toronto Venture Exchange (TSX-V).

A total of 6,119 shares was traded during the session, with total trades of 27, while having an average volume of 4,634 in the last five days.

The TSX-V overall saw 1,535 price advancers against 3,670 declines and 135 unchanged.

During the prior 52 weeks, RX.VN has traded as high as $9.26 (December 29,2023) and low as $7.03 (July 06,2023). Moreover, the shares have boosted 14.12 percent in the last 52 weeks, while they have dipped -6.18% this year.

It announced a 0.04 dividend on February 07/24, with an February 28/24 ex-date and March 15/24 pay day.

Following today's trading, Biosyent Inc has a market capitalization of $99.90 million on a float of 11,616 shares outstanding. Its annual EPS is $0.53.

Biosyent Inc is a TSX Drug Specialty & Generic company headquartered in Mississauga, CAN.

Based on 1.00 analysts, Biosyent Inc gets an average recommendation of "Moderate Buy" according to Zacks. Currently, there are 1 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe